Articles tagged with Metabolic Syndrome
A malaria drug, chloroquine, was found to improve symptoms of metabolic syndrome in mice by reducing atherosclerosis, lowering blood pressure, and improving blood sugar tolerance. The drug works by activating a particular stress pathway that mediates susceptibility to the syndrome.
Researchers found that chloroquine eased many symptoms of metabolic syndrome in mice, reducing blood pressure, hardening and narrowing of the arteries, and improving blood sugar tolerance. A pilot clinical trial is underway to test its safety and effectiveness in humans.
Study suggests that statins may be beneficial for preventing complications of metabolic syndrome, a condition characterized by low-grade inflammation and insulin resistance. The researchers found marked reductions in inflammatory biomarkers and improvements in vascular health in patients treated with statins.
A study suggests that more aggressive treatment with statins is necessary to lower LDL cholesterol in patients with metabolic syndrome and coronary heart disease. The analysis found that intensive therapy with atorvastatin significantly reduced the risk of major cardiovascular events, particularly in patients with metabolic syndrome.
Researchers discovered a key component in the insulin pathway that contributes to metabolic syndrome and insulin resistance. The study found that reducing this gene's function can lower glucose and lipid levels and even extend lifespan.
A study of 93 patients found that more than half with clozapine treatment had metabolic syndrome, a group of conditions increasing heart disease and diabetes risk. Regular monitoring is crucial for patients taking clozapine due to its potential long-term health implications.
Pre-diabetes and undiagnosed type 2 diabetes affect millions, increasing heart disease risk. Research shows nearly 22% of people aged 65+ have diabetes, with significant disparities among ethnic groups.
Men with metabolic syndrome are nearly twice as likely to develop heart failure as those without. The condition may directly affect the heart and boost fatty deposits in arteries, say researchers. Insulin resistance is thought to play a key role in this process.
The study found that a specialized clinic team reduced the ten-year risk of cardiovascular disease by nearly 20% in obese patients with metabolic syndrome after six months. The collective body mass index, waist size, triglycerides, and HDL cholesterol levels dropped significantly, indicating a substantial reduction in cardiovascular risk.
A study found that blocking key protein etanercept reduced inflammatory markers in patients with metabolic syndrome, a condition characterized by abdominal obesity, high triglycerides, and low HDL cholesterol. The treatment also showed promise in reducing cardiovascular risk factors.
A new study finds that PCOS is associated with elevated cholesterol levels, insulin resistance, and metabolic syndrome in mothers. The long-term health consequences of PCOS are significant, and mothers should be screened for cardiovascular disease risk factors.
A study found that nearly half of elderly Beijing residents have metabolic syndrome, a cluster of five risk factors for cardiovascular disease. The prevalence of metabolic syndrome in China is on par with Western populations, posing a significant burden on the healthcare system.
A recent study by UC Davis researchers found that grape seed extract can significantly reduce blood pressure in individuals with metabolic syndrome. The one-month study involved 24 patients, who experienced an average drop of 12 millimeters in systolic and 8 millimeters in diastolic blood pressure.
Scientists discovered that mice lacking the DNA repair enzyme NEIL1 develop severe obesity and metabolic syndrome, with enlarged livers and insulin resistance. The study suggests an important role for NEIL1 in preventing metabolic disorders.
A multidisciplinary team at UCI will investigate the connection between genetic variations in mitochondria and metabolic syndrome symptoms. The research may lead to new diagnostic tools and treatments for conditions like diabetes and cardiovascular disease.
A Mediterranean-style diet rich in olive oil, whole grains, fruits, vegetables, and nuts may reduce the risk of cardiovascular disease in patients with metabolic syndrome. The diet's effects are attributed to its action on inflammation and dysfunction of blood vessel cells.
A recent study from Tufts University found that higher whole-grain intake is associated with lower fasting blood sugar levels and a reduced risk of metabolic syndrome in elderly individuals. Consuming three or more servings of whole grains per day may help mitigate insulin resistance and impaired glucose tolerance.
A study of 298 simultaneous kidney-pancreas transplant recipients found metabolic syndrome to be a risk factor for long-term kidney dysfunction. Patients with metabolic syndrome were 10 times more likely to experience reduced kidney function three years post-transplant compared to those without it.
A three-week diet and exercise study shows that Type 2 diabetes and metabolic syndrome can be reversed through lifestyle changes, with half of participants experiencing a clinical diagnosis reversal. The regimen improved factors contributing to heart disease, such as insulin resistance and high cholesterol.
A study found that veterans with CMI report poorer quality of life and utilize more healthcare services. The condition is also linked to metabolic syndrome, which doubles the risk of coronary heart disease, diabetes, and cirrhosis.
Researchers argue that reducing carbohydrate intake is key to treating metabolic syndrome, as it can restore insulin responses and improve overall health. Studies have shown that carbohydrate reduction is more effective than fat reduction in addressing the various components of metabolic syndrome.
Researchers followed nearly 6,000 women with metabolic syndrome over nine years, finding that cardiorespiratory fitness reduced overall deaths and heart disease-specific deaths to rates similar to those without the condition. Higher levels of cardiorespiratory fitness were associated with lower risk factors and improved heart health.
A new European consensus definition of the metabolic syndrome (MetS) reveals a high prevalence, with 38% of men and 36% of women affected. The MetS is associated with increased cardiovascular mortality rates, particularly in diabetic women, highlighting gender-specific risk factors.
The metabolic syndrome is frequently present in middle-aged subjects, coinciding with adverse cardiovascular changes, including inflammation, thickening of the heart, and atherosclerosis. Every additional component of MS increases the likelihood of cardiovascular damage.
The study found a strong social gradient in metabolic syndrome, with individuals from lower socio-economic positions having a higher risk of the condition. Despite healthier lifestyles among those with higher education levels, the risk was still significantly lower for those with higher education.
Retinoid X receptor heterodimers are potential therapeutic targets for metabolic syndrome, according to a review article by UT Southwestern's Dr. David Mangelsdorf and Dr. Andrew Shulman. Activating specific RXR complexes may help regulate lipid metabolism and reduce the risk of heart disease and other related illnesses.
A VCU study found that low-dose oral contraceptives double the risk of cardiovascular events, such as heart attacks and strokes, among women. Women with PCOS or metabolic disorders are particularly at increased risk.
Researchers at Cedars-Sinai Medical Center found that patients with metabolic syndrome and moderate coronary calcium have a greater chance of having blockage in their arteries. The study analyzed 1,043 patients without known heart disease and found that those with metabolic syndrome had a significantly higher risk of ischemia during st...
A study examined the prevalence of metabolic syndrome in heart attack patients and found that 46% met the criteria. Patients with metabolic syndrome were older, more likely to be women, and had worse in-hospital outcomes, including increased risk of heart failure.
Researchers at Rutgers are studying the effects of plant extracts on metabolic syndrome, a condition characterized by obesity, hypertension, and high insulin levels. The center aims to identify chemical compounds with therapeutic potential and develop new treatments for this growing public health concern.
Researchers discovered significant differences in lipoprotein sizes and subclasses among severely obese white and black children, indicating higher cardiovascular risk for the former group. This study emphasizes the importance of addressing obesity-related health disparities in childhood.
A recent study by Fred W. Turek and Joseph Bass found a possible link between sleep disturbances and metabolic syndrome in mutant mice. The research suggests that altered circadian rhythms and hormone regulation, including leptin and ghrelin, may play a role in the development of obesity, diabetes, and cardiovascular disease.
A new study on anthrax attacks suggests post-attack vaccination plus antibiotic therapy is the most effective strategy. Meanwhile, an analysis of data from a large randomized trial found that both metformin and lifestyle changes can slow metabolic syndrome progression, with lifestyle change providing greater benefits.
A recent study found a high prevalence of metabolic syndrome and overweight among Chinese adults, with increased risk factors in northern China and urban residents compared to rural areas. The findings suggest that economic development and lifestyle changes may contribute to the growing obesity crisis in China.
A recent study found that nearly a third of college students are overweight, while six percent are pre-diabetic. The findings suggest that early screening is crucial for preventing long-term health problems. Researchers also discovered that polyunsaturated fat intake may be linked to slower growth of prostate cancer.
Research suggests that excessive visceral and muscle adipose tissue accumulation is associated with a higher prevalence of metabolic syndrome in older adults, regardless of their body weight. Visceral fat was linked to an increased risk, while subcutaneous thigh fat showed an inverse association in obese individuals.
Study reveals nearly two times higher likelihood of metabolic syndrome in women with PCOS, leading to increased risk of early-onset cardiovascular disease. Women with both conditions exhibit more severe insulin resistance.
Researchers found that inhibiting SCD1 decreased body fat and prevented obesity and metabolic syndrome in mice. Blocking SCD1 also increased expression of genes involved in energy expenditure, providing insights into its role in metabolism.
A new study found that pre-diabetes prevention efforts are worth every penny, with a one-on-one weight loss and exercise program showing a 58% reduction in Type 2 diabetes risk. Lifestyle interventions could delay the onset of diabetes by an average of 11 years and reduce the risk of developing diabetes by 20%.
Researchers discovered that mice lacking two related fatty acid binding proteins exhibit striking changes in their lipid profiles and strong resistance to diet-induced obesity and other conditions. The proteins appear to play a crucial role in integrating metabolic and inflammatory responses underlying metabolic syndrome.
A new study suggests that insufficient sleep may be a contributing factor to weight gain and the development of metabolic syndrome. This condition increases the risk of serious diseases such as diabetes and cardiovascular disease.
Research found that total sleep time decreased as body mass index increased, except in severely obese individuals. Sleeping less than 16 minutes per day was associated with a lower BMI.
A review of nine studies found that pre-diabetics using weight-loss interventions can lose between 2-3 kilograms or four to six pounds in one to two years. The interventions also decreased blood sugar levels, blood pressure, and cholesterol levels slightly among pre-diabetics.
The study found substantial improvements in exercise groups, including a 16% increase in aerobic fitness and a 17% increase in strength fitness. In contrast, the control group showed less improvement, indicating that exercise is an effective treatment for metabolic syndrome in older adults.
Researchers found that apocynin reduced ROS production in fat cells, restored adipocytokine production, and improved diabetes. Accumulated fatty tissue is a major source of ROS in obesity, acting as an early trigger of metabolic syndrome.
Heavy lifetime alcohol users have a 60 percent greater risk of developing metabolic syndrome compared to those in the lowest category. The study found that drinking patterns independently predict the risk of metabolic syndrome.
A five-year study of over 2,600 elders found a significant link between the metabolic syndrome and cognitive decline. Elders with both the syndrome and high levels of inflammation showed a higher risk of cognitive decline, highlighting the importance of addressing cardiovascular risk factors to prevent dementia.
A study published in JAMA found that metabolic syndrome is associated with poor cognitive outcomes in elderly individuals. Participants with the metabolic syndrome and high inflammation showed a significant increase in cognitive impairment and four-year decline in cognitive testing scores compared to those without the metabolic syndrome.
Researchers found a strong correlation between PCOS and initial evidence of calcium deposits signaling blood vessel disease. Women with both PCOS and metabolic cardiovascular syndrome were at an even greater risk of calcification in coronary arteries.
A recent study found that maintaining a stable weight, even for obese individuals, significantly reduces the risk of heart disease. The study, which followed over 2,500 young adults for 15 years, revealed that those who gained weight were nearly five times more likely to develop metabolic syndrome and related health issues.
A study found that surgical weight loss programs significantly improved metabolic syndrome symptoms, with a 95.6% resolution rate for patients with the condition. Laparoscopic gastric bypass surgery resulted in greater weight loss and better blood lipid profiles compared to vertical banded gastroplasty.
A recent study examining obese postmenopausal women found that visceral fat storage was the main determinant of metabolic syndrome and increased cardiovascular disease risk. High-intensity exercise and general weight reduction were identified as potential strategies to reduce this risk.
Researchers found that lean mass, intra-abdominal fat, and inflammation biomarker sTNFR1 are higher in women with metabolic syndrome, independently related to its severity. Analysis of these factors can help doctors identify postmenopausal women at increased risk for diabetes and heart disease.
A randomized trial found that a Mediterranean-style diet reduced the prevalence of metabolic syndrome by approximately one half after two years. The diet was rich in whole grains, fruits, vegetables, legumes, walnuts, and olive oil.
The study found that approximately 1 in 5 subjects had previously undiagnosed diabetes, while over 1 in 4 had impaired glucose tolerance. Lifestyle changes and medication may help prevent the progression of impaired glucose tolerance to full-blown diabetes and its associated complications.
Feldman et al report that donepezil treatment for six days is associated with a total societal cost saving of $224 per patient. The American Brain Coalition (ABC) was established to advocate for increased support for biomedical research.
A national health survey found that depression in young women is associated with an increased risk of developing the metabolic syndrome, a cluster of factors linked to heart disease. The study also suggests that depression can cause physiological changes that increase the risk of heart disease.
A recent study published in the New England Journal of Medicine found that nearly 50% of severely obese youth develop metabolic syndrome. The condition is associated with worsening body mass index and insulin resistance, increasing risk for type 2 diabetes and cardiovascular disease.
Crestor effectively tackles elevated non-HDL cholesterol levels, a key risk factor for heart attacks and strokes, in patients with metabolic syndrome. The medication demonstrates significant results in reducing the incidence of these cardiovascular diseases.
A new study suggests that treating metabolic syndrome's risk-factor components might reduce stroke risk before Type 2 diabetes develops. Men with metabolic syndrome have a 78% greater stroke risk, while women have more than double the risk compared to those without the condition.